{"transactions":[{"id":753336,"issuer":{"id":13670,"kind":"organization","name":"Veradigm Inc.","symbol":"MDRX"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T16:30:31.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":42507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock Units granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026 (the \"Grant Date\"). The grant vests 100% on the first anniversary of the Grant Date."}],"balance_after":131125,"source":{"system":"sec-edgar","filing":"0001193125-26-255563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000119312526255563/ownership.xml","form_type":"4"}},{"id":863640,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"officer":true,"officer_title":"CCSO"}}],"security":"Stock Options","published_at":"2026-03-04T17:25:43.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":48728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 6/48ths on September 2, 2026 and 1/48th per month thereafter."}],"balance_after":48728,"derivative":{"exercise_price":53.47,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":48728},"source":{"system":"sec-edgar","filing":"0001437749-26-006935","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000143774926006935/rdgdoc.xml","form_type":"4"}},{"id":908744,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T17:36:43.000Z","date":"2026-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of outstanding options to purchase ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued) Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of the $21.00 over the applicable exercise price per Ordinary Share under such Option immediately prior to the Effective Time and (ii) a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share subject to such Option immediately prior to the Effective Time (without regard to vesting), contingent upon achievement of certain milestones."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of outstanding options to purchase ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued) Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of the $21.00 over the applicable exercise price per Ordinary Share under such Option immediately prior to the Effective Time and (ii) a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share subject to such Option immediately prior to the Effective Time (without regard to vesting), contingent upon achievement of certain milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the disposition of outstanding options to purchase ordinary shares of Avadel Pharmaceuticals plc (\"Issuer\"), nominal value $0.01 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement, dated as of October 22, 2025, as amended by Amendment No. 1 to the Transaction Agreement dated November 18, 2025, (together the \"Transaction Agreement\") by and between Issuer and Alkermes plc (\"Parent\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Parent acquired Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(continued) Pursuant to the Transaction Agreement, on February 12, 2026, the effective time of the Scheme (the \"Effective Time\"), each outstanding Option (whether or not vested) was canceled and exchanged for the right to receive (i) an amount in cash (less applicable tax and any other mandatory withholdings), equal to the product of (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of the $21.00 over the applicable exercise price per Ordinary Share under such Option immediately prior to the Effective Time and (ii) a non-transferable contingent value right entitling the holders to a potential additional cash payment of $1.50 per share subject to such Option immediately prior to the Effective Time (without regard to vesting), contingent upon achievement of certain milestones."}],"balance_after":0,"derivative":{"exercise_price":9.59,"expiration_date":"2035-05-13","underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-26-014449","document":"tm266121-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000110465926014449/tm266121-10_4seq1.xml","form_type":"4"}},{"id":1126528,"issuer":{"id":13670,"kind":"organization","name":"Veradigm Inc.","symbol":"MDRX"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T19:43:33.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":46512,"price":4.3,"value":200001.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock Units granted under the Veradigm, Inc. Amended and Restated 2024 Stock Incentive Plan on June 2, 2025 (the \"Grant Date\"). The grant vests 100% on the first anniversary of the Grant Date."}],"balance_after":88618,"source":{"system":"sec-edgar","filing":"0000950170-25-081240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017025081240/ownership.xml","form_type":"4"}},{"id":1151640,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-13T18:01:12.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options become exercisable in four equal annual installments on each of the first four anniversaries following the 05/13/2025 grant date, subject to the Reporting Person's continued service at each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":9.59,"expiration_date":"2035-05-13","underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-047924","document":"tm2514868-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000110465925047924/tm2514868-2_4seq1.xml","form_type":"4"}},{"id":1286327,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T17:27:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-013741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017025013741/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1286326,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T17:27:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":87180,"source":{"system":"sec-edgar","filing":"0000950170-25-013741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017025013741/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-03"}},{"id":1288411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-03T11:33:51.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":35900,"price":1.73,"value":62107.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":35900,"derivative":{"exercise_price":1.73,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":35900},"source":{"system":"sec-edgar","filing":"0000950170-25-012096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017025012096/ownership.xml","form_type":"4"}},{"id":1288410,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-03T11:33:51.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":17950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":87180,"source":{"system":"sec-edgar","filing":"0000950170-25-012096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017025012096/ownership.xml","form_type":"4"}},{"id":1473954,"issuer":{"id":13670,"kind":"organization","name":"Veradigm Inc.","symbol":"MDRX"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T17:00:07.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":42106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock Units granted under the Veradigm, Inc. 2024 Stock Incentive Plan on May 31, 2024 (the \"Grant Date\").  The grant vests 50% on grant Date and the other 50%  on the first anniversary of the Grant Date."}],"balance_after":42106,"source":{"system":"sec-edgar","filing":"0000950170-24-075699","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000095017024075699/ownership.xml","form_type":"4"}},{"id":1504604,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-23T16:17:44.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":6703,"price":7.811,"value":52357.133,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in February 2024."}],"balance_after":449092,"source":{"system":"sec-edgar","filing":"0001628280-24-024949","document":"wk-form4_1716495453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000162828024024949/wk-form4_1716495453.xml","form_type":"4"}},{"id":1626966,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T16:56:54.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":6928,"price":8.7463,"value":60594.3664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":452795,"source":{"system":"sec-edgar","filing":"0001610717-24-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000161071724000082/form4.xml","form_type":"4"}},{"id":1675842,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T21:04:50.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":83685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":83685,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":83685},"source":{"system":"sec-edgar","filing":"0001209191-24-001981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919124001981/doc4.xml","form_type":"4"}},{"id":1675841,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T21:04:50.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":13948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on January 19, 2025."}],"balance_after":69230,"source":{"system":"sec-edgar","filing":"0001209191-24-001981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919124001981/doc4.xml","form_type":"4"}},{"id":1677235,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T16:37:12.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":145000,"derivative":{"exercise_price":8.78,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001628280-24-001686","document":"wk-form4_1705613823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000162828024001686/wk-form4_1705613823.xml","form_type":"4"}},{"id":1677234,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-18T16:37:12.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":112750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":459723,"source":{"system":"sec-edgar","filing":"0001628280-24-001686","document":"wk-form4_1705613823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000162828024001686/wk-form4_1705613823.xml","form_type":"4"}},{"id":1731919,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T17:20:51.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":4714,"price":4.3622,"value":20563.4108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in August 2023."}],"balance_after":346973,"source":{"system":"sec-edgar","filing":"0001628280-23-039904","document":"wk-form4_1700691637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000162828023039904/wk-form4_1700691637.xml","form_type":"4"}},{"id":1799152,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-23T16:48:13.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":4733,"price":3.5518,"value":16810.6694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $3.511 to $3.551843, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":348687,"source":{"system":"sec-edgar","filing":"0001628280-23-030414","document":"wk-form4_1692823684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000162828023030414/wk-form4_1692823684.xml","form_type":"4"}},{"id":1879087,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-25T08:52:40.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":4711,"price":3.6532,"value":17210.2252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in February 2023."}],"balance_after":353420,"source":{"system":"sec-edgar","filing":"0001104659-23-064389","document":"tm2316962-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000110465923064389/tm2316962-3_4seq1.xml","form_type":"4"}},{"id":1981802,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T16:36:26.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":5586,"price":3.001,"value":16763.586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":355131,"source":{"system":"sec-edgar","filing":"0001567619-23-004210","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761923004210/doc1.xml","form_type":"4"}},{"id":2061157,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T16:24:50.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":351000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":351000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":351000},"source":{"system":"sec-edgar","filing":"0001567619-23-000643","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761923000643/doc1.xml","form_type":"4"}},{"id":2061156,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-06T16:24:50.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":360717,"source":{"system":"sec-edgar","filing":"0001567619-23-000643","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761923000643/doc1.xml","form_type":"4"}},{"id":2080357,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-20T17:21:49.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":77160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":77160,"derivative":{"exercise_price":2.74,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":77160},"source":{"system":"sec-edgar","filing":"0001209191-22-062191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919122062191/doc4.xml","form_type":"4"}},{"id":2080356,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T17:21:49.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":38580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 16, 2023."}],"balance_after":55282,"source":{"system":"sec-edgar","filing":"0001209191-22-062191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919122062191/doc4.xml","form_type":"4"}},{"id":2106050,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-23T16:15:59.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":3303,"price":1.9493,"value":6438.5379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":282717,"source":{"system":"sec-edgar","filing":"0001567619-22-020848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922020848/doc1.xml","form_type":"4"}},{"id":2106049,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-23T16:15:59.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":22,"price":1.945,"value":42.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":286020,"source":{"system":"sec-edgar","filing":"0001567619-22-020848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922020848/doc1.xml","form_type":"4"}},{"id":2106048,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-23T16:15:59.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":131,"price":1.9418,"value":254.3758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":286042,"source":{"system":"sec-edgar","filing":"0001567619-22-020848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922020848/doc1.xml","form_type":"4"}},{"id":2175528,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-24T17:45:46.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":64,"price":0.9801,"value":62.7264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":286173,"source":{"system":"sec-edgar","filing":"0001567619-22-016647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922016647/doc1.xml","form_type":"4"}},{"id":2175527,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-24T17:45:46.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":3356,"price":0.9837,"value":3301.2972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":286237,"source":{"system":"sec-edgar","filing":"0001567619-22-016647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922016647/doc1.xml","form_type":"4"}},{"id":2239641,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:02:59.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":910,"price":0.6357,"value":578.487,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":289593,"source":{"system":"sec-edgar","filing":"0001567619-22-012556","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922012556/doc1.xml","form_type":"4"}},{"id":2239640,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-08T20:02:59.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":43010,"price":0.6509,"value":27995.209,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":290503,"source":{"system":"sec-edgar","filing":"0001567619-22-012556","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922012556/doc1.xml","form_type":"4"}},{"id":2260929,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-23T16:35:12.000Z","date":"2022-05-20","kind":"sale","acquired":false,"shares":3425,"price":0.6714,"value":2299.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2022."}],"balance_after":333513,"source":{"system":"sec-edgar","filing":"0001567619-22-011522","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922011522/doc1.xml","form_type":"4"}},{"id":2373333,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T16:54:22.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":3400,"price":0.67,"value":2278.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":333938,"source":{"system":"sec-edgar","filing":"0001567619-22-005657","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922005657/doc1.xml","form_type":"4"}},{"id":2437192,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T19:47:59.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":195000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001567619-22-001139","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922001139/doc1.xml","form_type":"4"}},{"id":2437191,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-12T19:47:59.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":338031,"source":{"system":"sec-edgar","filing":"0001567619-22-001139","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761922001139/doc1.xml","form_type":"4"}},{"id":2460258,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T18:58:03.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":20903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":20903,"derivative":{"exercise_price":9.81,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":20903},"source":{"system":"sec-edgar","filing":"0001209191-21-071170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919121071170/doc4.xml","form_type":"4"}},{"id":2460257,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T18:58:03.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":10452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 22, 2022."}],"balance_after":16702,"source":{"system":"sec-edgar","filing":"0001209191-21-071170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000120919121071170/doc4.xml","form_type":"4"}},{"id":2496729,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T16:08:09.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":643,"price":0.9919,"value":637.7917,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":197030,"source":{"system":"sec-edgar","filing":"0001567619-21-021164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921021164/doc1.xml","form_type":"4"}},{"id":2532260,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-10-29T19:56:41.000Z","date":"2021-10-08","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021."}],"balance_after":197673,"source":{"system":"sec-edgar","filing":"0001567619-21-019031","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921019031/doc1.xml","form_type":"4"}},{"id":2592988,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T18:07:52.000Z","date":"2021-08-20","kind":"sale","acquired":false,"shares":630,"price":1.32,"value":831.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":44673,"source":{"system":"sec-edgar","filing":"0001567619-21-016286","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921016286/doc1.xml","form_type":"4"}},{"id":2701920,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-21T16:49:07.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":611,"price":7.0878,"value":4330.6458,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":45303,"source":{"system":"sec-edgar","filing":"0001567619-21-010924","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921010924/doc1.xml","form_type":"4"}},{"id":2837245,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-24T16:40:24.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":611,"price":6.8825,"value":4205.2075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":45914,"source":{"system":"sec-edgar","filing":"0001567619-21-004775","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921004775/doc1.xml","form_type":"4"}},{"id":2914252,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T19:11:16.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":146755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":146755,"derivative":{"exercise_price":6.35,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":146755},"source":{"system":"sec-edgar","filing":"0001567619-21-000764","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921000764/doc1.xml","form_type":"4"}},{"id":2914251,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-07T19:11:16.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":32612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":46525,"source":{"system":"sec-edgar","filing":"0001567619-21-000764","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761921000764/doc1.xml","form_type":"4"}},{"id":3029381,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-17T18:35:43.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":6087,"price":6.1055,"value":37164.1785,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $6.05 to $6.1611, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":13913,"source":{"system":"sec-edgar","filing":"0001567619-20-016851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761920016851/doc1.xml","form_type":"4"}},{"id":3141706,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T17:47:15.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":232750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty Five Percent (25%) of the shares subject to the option vest on May 18, 2021 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":232750,"derivative":{"exercise_price":7.7,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":232750},"source":{"system":"sec-edgar","filing":"0001567619-20-010851","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761920010851/doc1.xml","form_type":"4"}},{"id":3141705,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":42060,"kind":"person","name":"Rodriguez Susan","position":1,"cik":"0001812511","reported_name":"Rodriguez Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-20T17:47:15.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001567619-20-010851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812511/000156761920010851/doc1.xml","form_type":"4"}}]}